Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The 8 Weeks, Multicenter, Randomized, Double-blind, Clinical Study To Evaluate Efficacy Of Treatment With Losartan/Amlodipine 100/5 mg Combination Compared To Amlodipine 10 mg Monotherapy In Hypertensive Patients Who Are Not Appropriately Respond To Amlodipine 5 mg Monotherapy

NCT01277822 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT01277822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01277822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The 8 Weeks, Multicenter, Randomized, Double-blind, Clinical Study To Evaluate Efficacy Of Treatment With Losartan/Amlodipine 100/5 mg Combination Compared To Amlodipine 10 mg Monotherapy In Hypertensive Patients Who Are Not Appropriately Respond To Amlodipine 5 mg Monotherapy
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
May 30, 2011
Completion date
April 22, 2013
Enrollment
334 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension